APPARENT NONCOMPETITIVE ANTAGONISM OF MUSCARINIC RECEPTOR MEDIATED CA2+ MOBILIZATION BY SOME MUSCARINIC ANTAGONISTS

被引:11
作者
KUKKONEN, J
AKERMAN, KEO
机构
[1] Department of Biochemistry and Pharmacy, Åbo Akademi University, SF-20521 Turku, Biocity
关键词
D O I
10.1016/0006-291X(92)92291-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ca2+ mobilizations in SH-SY5Y and IMR-32 human neuroblastoma cell lines were measured using the fluorescent Ca2+ indicator fura-2. A variety of antagonists (atropine, pirenzepine, 4-DAMP and N-methyl-scopolamine) inhibited carbamyl choline-induced transient Ca2+ mobilization both in a competitive and a noncompetitive manner. The apparent noncompetitive inhibition constants were lower in IMR-32 than in SH-SY5Y cells even when the competitive inhibition constants were similar. This may relate to the previously reported differential expression of muscarinic receptor subtypes in these cell lines. © 1992.
引用
收藏
页码:919 / 924
页数:6
相关论文
共 24 条
[1]   12-O-TETRADECANOYLPHORBOL 13-ACETATE AND FORSKOLIN MODIFY MUSCARINIC RECEPTOR-LINKED CA-2+ MOBILIZATION IN SH-SY5Y NEUROBLASTOMA-CELLS THROUGH DIFFERENT MECHANISMS [J].
AKERMAN, KEO ;
HEIKKILA, JE .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (02) :497-504
[2]  
BEACH JE, 1988, J PHARMACOL EXP THER, V246, P548
[3]  
BIEDLER JL, 1973, CANCER RES, V33, P2643
[4]  
CLEMENTI F, 1986, J NEUROCHEM, V47, P291
[5]   SIMPLE GRAPHICAL METHOD FOR DETERMINING INHIBITION CONSTANTS OF MIXED, UNCOMPETITIVE AND NON-COMPETITIVE INHIBITORS [J].
CORNISHB.A .
BIOCHEMICAL JOURNAL, 1974, 137 (01) :143-144
[6]  
DEJONG J, 1990, RES COMMUN CHEM PATH, V68, P275
[7]   DIFFERENTIAL AFFINITIES OF AF-DX 116, ATROPINE AND PIRENZEPINE FOR MUSCARINIC RECEPTORS OF GUINEA-PIG GASTRIC FUNDUS, ATRIA AND URINARY-BLADDER - MIGHT ATROPINE DISTINGUISH AMONG MUSCARINIC RECEPTOR SUBTYPES [J].
DELTACCA, M ;
DANESI, R ;
BLANDIZZI, C ;
BERNARDINI, MC .
PHARMACOLOGY, 1990, 40 (05) :241-249
[8]  
DUCKLES SP, 1990, J PHARMACOL EXP THER, V253, P608
[9]  
ELFAKAHANY EE, 1988, J PHARMACOL EXP THER, V247, P934
[10]  
FISHER SK, 1987, MOL PHARMACOL, V32, P81